Koroner arter hastalığı-1

References (4)

1. World Health Report 1999: Making a Difference. Geneva, World Health Organization, 1999
2. Murray CJL, Lopez AD: The Global Burden of Disease.Cambridge, MA, Harvard School of Public Health, 1996
3. Onat A, Keleş I, Çetinkaya A, ve ark. On yıllık TEKHARF çalışması verilerine göre Türk erişkinlerinde koroner kökenli ölümlerin prevalansı yüksek. Türk Kardiyol Dern Arş 29: 8-19, 2001 4- Türk Kardiyoloji Derneği Koroner Kalp Hastalığı Primer ve Sekonder Koruma Kılavuzu, 2001 5- Wilson PW, D'Agostino RB, Levy D,et al: Prediction of coronary heart disease using risk factor catagories.Circulation 97:1837-1847,1998 6- D'Agostino RB, Russell MW, Huse DM, et al:Primary and subsequent coronary risk appraisal: New results from the Framingham study. Am Heart J 139: 272-281, 2000 7- Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.Arch Intern Med. 1992 Jan;152(l):56-64
4. Ridker PM: Novel risk factors and markers for coronary disease. Adv Intern Med 45: 391-418,2000 9- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Heart,Lung, and Blood Institute, NIH Publication No. 01-3670, May 2001 10- Prof.Dr.Alberti: The new definition is to some extent an amalgam of the three previas major definitions by WFO European Group for Study of Insulin Rezistance and Adult Treatment Panel III 17 May 2005 11- Mahley RW, Palaoğlu E, Atak Z, et al: Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859 12- Onat A, Sansoy V. Halkımızda koroner hastalığın başsuçlusu metabolik sendrom: Sıklığı, unsurları, koroner risk ile ilişkisi ve yüksek risk kriterleri. Türk Kardiyoloji Dern Arş 30:8-15,2002 13- Witztum JL, Berliner JA: Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol 9:441-448,1998 14- Rong JX, Rangaswamy S, Shen L, et al: Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler Thromb Vase Biol 18:1885-1894, 1998 15- Clarkson TB, Prichart RW,Morgan TM,et al: Remodeling of coronary arteries in human and nonhuman primates. JAMA 271: 289-294, 1994 16- Kawamoto A, Gwon HC, Iwaguro H,et al. Therapeutic potential of ex vivo expanded endothelia